Neurocrine Biosciences, Inc. $(NBIX)$ is currently at $124.16, up $14.41 or 13.13%
--Would be highest close since Feb. 6, 2025, when it closed at $150.51
--On pace for largest percent increase since Nov. 2, 2017, when it rose 19.45%
--Currently up five of the past six days
--Currently up three consecutive days; up 16.48% over this period
--Best three day stretch since the three days ending March 26, 2020, when it rose 17.1%
--Down 9.04% year-to-date
--Down 19% from its all-time closing high of $153.29 on Jan. 30, 2025
--Down 13.29% from 52 weeks ago (May 7, 2024), when it closed at $143.19
--Down 19% from its 52-week closing high of $153.29 on Jan. 30, 2025
--Up 41.83% from its 52-week closing low of $87.54 on April 8, 2025
--Traded as high as $130.46; highest intraday level since Feb. 7, 2025, when it hit $132.00
--Up 18.87% at today's intraday high; largest intraday percent increase since Nov. 2, 2017, when it rose as much as 23.03%
All data as of 10:00:13 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
May 06, 2025 10:02 ET (14:02 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。